FTDI
First Trust Direct Indexing’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-54,308
| Closed | -$4.55M | – | 126 |
|
|
2024
Q3 | $4.55M | Buy |
54,308
+8,518
| +19% | +$714K | 0.24% | 75 |
|
|
2024
Q2 | $3.53M | Buy |
45,790
+7,284
| +19% | +$561K | 0.22% | 84 |
|
|
2024
Q1 | $2.64M | Buy |
38,506
+3,482
| +10% | +$238K | 0.2% | 100 |
|
|
2023
Q4 | $2.02M | Buy |
35,024
+2,187
| +7% | +$126K | 0.18% | 122 |
|
|
2023
Q3 | $1.73M | Sell |
32,837
-710
| -2% | -$37.5K | 0.2% | 115 |
|
|
2023
Q2 | $1.81M | Buy |
33,547
+1,802
| +6% | +$97.5K | 0.2% | 110 |
|
|
2023
Q1 | $1.59M | Buy |
31,745
+1,666
| +6% | +$83.4K | 0.19% | 121 |
|
|
2022
Q4 | $1.39M | Buy |
30,079
+560
| +2% | +$25.9K | 0.18% | 132 |
|
|
2022
Q3 | $1.14M | Buy |
29,519
+1,382
| +5% | +$53.5K | 0.17% | 151 |
|
|
2022
Q2 | $1.05M | Buy |
28,137
+518
| +2% | +$19.3K | 0.15% | 184 |
|
|
2022
Q1 | $1.22M | Buy |
27,619
+2,235
| +9% | +$99K | 0.15% | 171 |
|
|
2021
Q4 | $1.08M | Sell |
25,384
-78
| -0.3% | -$3.31K | 0.14% | 172 |
|
|
2021
Q3 | $1.11M | Buy |
25,462
+3,886
| +18% | +$169K | 0.16% | 153 |
|
|
2021
Q2 | $923K | Buy |
21,576
+4,008
| +23% | +$171K | 0.14% | 187 |
|
|
2021
Q1 | $679K | Buy |
17,568
+1,112
| +7% | +$43K | 0.18% | 163 |
|
|
2020
Q4 | $592K | Buy |
+16,456
| New | +$592K | 0.16% | 161 |
|